Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Renée J.G. Arnold"'
Autor:
Sean Ekins, Nadia K. Litterman, Renée J.G. Arnold, Robert W. Burgess, Joel S. Freundlich, Steven J. Gray, Joseph J. Higgins, Brett Langley, Dianna E. Willis, Lucia Notterpek, David Pleasure, Michael W. Sereda, Allison Moore
Publikováno v:
F1000Research, Vol 4 (2015)
This brief review of current research progress on Charcot-Marie-Tooth (CMT) disease is a summary of discussions initiated at the Hereditary Neuropathy Foundation (HNF) scientific advisory board meeting on November 7, 2014. It covers recent published
Externí odkaz:
https://doaj.org/article/3547c770fb444cc882536cb3aeb4f6a8
Autor:
Renée J.G. Arnold, Lida Bighash, Alejandro Bryón Nieto, Gabriela Tannus Branco de Araújo, Juan Gabriel Gay-Molina, Federico Augustovski
Publikováno v:
F1000Research, Vol 4 (2015)
Compared to a decade ago, nearly three times as many drugs for rare diseases are slated for development. This article addresses the market access issues associated with orphan drug status in Europe and the United States in contrast to the legislation
Externí odkaz:
https://doaj.org/article/17a30706e1d8424e89a9ad9dda2b2ec8
Autor:
Helen J. Lachmann, Renée J.G. Arnold, Marco Gattorno, Isabelle Koné-Paut, Alberto Ferreira, Jasmin Kümmerle-Deschner
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 1, Iss 2 (2013)
**Background:** Cryopyrin-associated periodic syndromes (CAPS) is a group of rare autoinflammatory diseases. Little is known about the burden of disease, patients’ views on treatment, and adverse events (AEs) with current therapy. **Objectives:**
Externí odkaz:
https://doaj.org/article/0c0a56d5846840a8a8fa44709b30736e
Autor:
Xavier G.L.V. Pouwels, Christopher J. Sampson, Renée J.G. Arnold, Manthan D. Janodia, Raymond Henderson, Mark Lamotte, Warren Cowell, John Borrill, Christine Huttin, Nayanabhirama Udupa, Cynthia L. Gong, Lee Shee Lan, Lance Brannman, Devin Incerti, K.V. Ramanath, Celine Pribil, Oleksandra Oleshchuk, Olena Pokotylo, Wendelin Schramm, Mark Nuijten
Publikováno v:
Value in health, 25(4), 473-479. Elsevier
Objectives: Health economic (HE) models are routinely used to support health policy and resource allocation decisions but are often considered “black boxes” that may be prone to error and bias. Open source models (OSMs) have been advocated to inc
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:487-504
Background and aims: Higher screening colonoscopy adenoma detection rates (ADRs) correlate with reduced risk of interval colorectal cancer (CRC). The Endocuff® device has been shown to improve ADRs compared to standard colonoscopy (SC). This cost-ef
Publikováno v:
Value in Health. 21:1278-1285
Background Genetic testing for nonsquamous advanced non–small cell lung cancer (aNSCLC) is recommended to guide first-line therapy. Activating mutations can be identified via single-gene testing or next-generation sequencing (NGS). Objectives To ev
Autor:
Neil X. Hawkins, Renée J.G. Arnold
Publikováno v:
Pharmacoeconomics ISBN: 9780429491368
Pharmacoeconomics
Pharmacoeconomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5378c1ce7fcc09dcf60c7751469652b2
https://doi.org/10.1201/9780429491368-15
https://doi.org/10.1201/9780429491368-15
Autor:
Renée J.G. Arnold
Publikováno v:
Pharmacoeconomics ISBN: 9780429491368
Pharmacoeconomics
Pharmacoeconomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e70b7de2285113caaa59374b3b17f5dc
https://doi.org/10.1201/9780429491368-19
https://doi.org/10.1201/9780429491368-19
Publikováno v:
Drugs-Real World Outcomes, Vol 5, Iss 4, Pp 217-224 (2018)
Drugs-Real World Outcomes
Drugs-Real World Outcomes
Background and Objective Aegis Sciences Corporation developed a test (InterACT Rx™) that objectively and definitively identifies substances known to interact with drug–drug interaction-prone medications commonly prescribed in the treatment of chr
Autor:
Philip Clarke, Edward C. F. Wilson, Deborah A. Marshall, Neil Hawkins, Tim Wrightson, Stirling Bryan, Mohsen Sadatsafavi, Sean Ekins, Anthony J. Hatswell, Renée J.G. Arnold, Will Sullivan, Sue Langham, Christopher Sampson
Publikováno v:
Pharmacoeconomics
Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open source implementation of decision analytic models. However, in the debate about the supposed advantages and disadvantages of gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ba7a62ea96b8a6acd78c9e941ee54e
https://europepmc.org/articles/PMC8237575/
https://europepmc.org/articles/PMC8237575/